Home > Blog

Introducing Sandbox Kesehatan 2025: A Catalyst for Health-Tech and Medtech Innovation in Indonesia

Introducing Sandbox Kesehatan 2025: A Catalyst for Health-Tech and Medtech Innovation in Indonesia

Dr. Hardyansyah, MPH-MMR Sp. KKLP
November 13, 2025

Contents

Indonesia’s health-technology ecosystem is evolving rapidly. With the launch of Sandbox Kesehatan 2025, Kemenkes provides a formal, structured pathway for innovators, start-ups and medical device companies to test, validate and scale solutions under regulatory supervision.

For global medical-device manufacturers, regulatory services and tech innovators, this Sandbox represents not only a launchpad for registration and certification but an opportunity to align with Indonesia’s regulatory future and market access roadmap.

What is Sandbox Kesehatan?

The Sandbox is described by Kemenkes as a “program of acceleration for health-technology innovation” — a controlled “safe space” where innovators can trial health technologies (devices, digital health, medical services) while receiving regulatory guidance and oversight.

Participants will benefit from:

  • Structured testing and piloting under regulatory supervision.
  • Mentorship and compliance support from Kemenkes and technical experts.
  • Official recognition and recommendation that strengthen market credibility.

This framework is strategic for companies targeting Indonesian healthcare procurement, medical device registration and regulatory alignment.

Why It Matters for Medtech & Regulatory Services Stakeholders

For medical-device manufacturers and regulatory-services firms like Product Registration Indonesia, the Sandbox offers distinct advantages:

  • Streamlined route to regulatory recognition: an innovation that completes the Sandbox cycle and receives a Kemenkes recommendation is more credible to hospitals, investors and distributors.
  • Embedded compliance early: The program brings regulatory readiness, including Halal, safety, and registration awareness, into the innovation lifecycle.
  • Accelerated market access: Technologies validated through the Sandbox may find faster access to Indonesian registration processes, procurement frameworks and partner networks.

How to Participate within the Timeline?

The registration period for Sandbox Kesehatan 2025 is open and participants should engage early to take full advantage of the cycle. Here is the step-by-step timeline:

PhaseTimelineWhat to Do
Registration Opens5 November 2025Visit sandbox.kemkes.go.id, click “Register”, create an account.
TKT Assessment (Technology Readiness Level)Within 1 week after registrationComplete the online questionnaire to determine your readiness and recommended Sandbox scheme (Innovation Development, Expanded Utilisation, Policy-Based Formation). Kemkes Sandbox
Form Submission & Document UploadBy end of November 2025Upload Company Deck, Innovation Description, Business Model, Supporting Documents (NDAs, declarations) via portal. Kemkes Sandbox
Email Verification & Account ActivationImmediately after submissionActivate your account via link sent in email from no-reply@sandbox.kemkes.go.id. Kemkes Sandbox
Dashboard Access & Innovation MatchingEarly December 2025Log in to Dashboard → see status, assess your submission, receive guidance on which scheme applies, begin pilot/test planning.
Sandbox Trial / Real-World TestingDecember 2025 – Q1 2026Conduct the testing phase under regulator supervision with defined metrics, dataset collection and risk assessment.
Evaluation & Recommendation IssuedQ2 2026Kemenkes reviews results, issues “Recommended”, “Conditionally Recommended”, or “Under Improvement” status. Innovations endorsed may display “Recommended by Kemenkes” badge. Ministry of Health Indonesia

Key Tip: Begin preparation early—document drafting, digital proof-of-concept, and stakeholder engagement should start before registration to maximise your chances.

The Reason Product Registration Indonesia is The Best Partner for Your Medtech Company

As a regulatory services partner specialising in Indonesia, we offer support in:

  • Preparation of your innovation for Sandbox eligibility, including regulatory mapping (Medical Device Registration, Halal Certification, digital health standards).
  • Documentation support, mentoring and strategic alignment with Kemenkes requirements.
  • Coordinating local representation, distributor match-making and market access advisory. By engaging PRI early, you improve your chances of acceptance and accelerate your market entry into Indonesia and ASEAN corridors.

The launch of Sandbox Kesehatan 2025 represents a significant opportunity for health-tech innovators, medtech device firms and regulatory-services providers to integrate compliance and innovation.

Frequently Asked Questions (FAQ) About the Sandbox Kesehatan

What is Sandbox Kesehatan?

Sandbox Kesehatan is a structured program launched by Kemenkes to accelerate the development of health-technology solutions by providing a safe, regulatory-supervised test environment and a faster path to market.

Who is eligible to join?

Individuals, research teams, start-ups, health-service providers and companies—both domestic and international—developing health-tech innovations (devices, digital platforms, services) can apply.

What types of innovation schemes are available?

The program offers three routes based on technology readiness: (1) Innovation Development, (2) Expanded Utilisation, and (3) Policy-Based Formation for mature projects aligned to national health priorities.

Is there a fee to participate?

Participation in the Sandbox registration is free of charge; however, you may incur costs for pilot deployment, regulatory consultancy or partner collaboration.

How long does the process take?

While timelines vary by innovation, following the structured cycle above, many projects complete testing and evaluation within 6-9 months from registration.

Will registration make me compliant with all Indonesian regulations?

Not automatically. The Sandbox gives you regulatory oversight and recommendation status, but standard registration (e.g., medical device NIE, Halal certification) may still be required.

What happens after the pilot phase?

At the end of the trial, Kemenkes issues a recommendation status. If ‘Recommended’, you may use the official badge and are eligible for wider deployment or procurement programmes.

Who do I contact for support?

For technical assistance or inquiries, email sandbox@kemkes.go.id or consult the FAQ section on the website.

Picture of Dr. Hardyansyah, MPH-MMR Sp. KKLP
Dr. Hardyansyah, MPH-MMR Sp. KKLP
Dr. Hardyansyah is a healthcare leader with over a decade of experience in clinical, operational, and executive roles—pioneering digital innovation and transforming healthcare delivery with vision, integrity, and purpose.
Get the latest product registration updates
Newsletter subsription

Inquiry Form

Our team is prepared to discuss your business needs and address any questions you may have. Fill out our inquiry form, and we’ll respond within one business day.

Contact Form
Submit with your company email for quicker response and priority handling.

Other ways to get in touch with us.

Related Article
Silent Threats: Navigating Heavy Metal Limits in Indonesian Natural Medicines
Global Halal Products Market Forecast: Surging to USD 4.5 Trillion by 2033
Mandatory Halal Certification 2026: BPJPH, BPOM, and Kemenkes Strengthen Synergy
Silent Threats: Navigating Heavy Metal Limits in Indonesian Natural Medicines
Global Halal Products Market Forecast: Surging to USD 4.5 Trillion by 2033
Silent Threats: Navigating Heavy Metal Limits in Indonesian Natural Medicines